5-[4-[2,7-bis(3,5-dimethylphenyl)carbazol-9-yl]-3-cyanophenyl]pyrimidine-2-carbonitrile
C40H29N5 — CID 165401521
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[4-[2,7-bis(3,5-dimethylphenyl)carbazol-9-yl]-3-cyanophenyl]pyrimidine-2-carbonitrile
5-[4-[2,7-bis(3,5-dimethylphenyl)carbazol-9-yl]-3-cyanophenyl]pyrimidine-2-carbonitrile (PubChem CID 165401521) has the molecular formula C40H29N5 and a molecular weight of 579.71 g/mol. Its IUPAC name is 5-[4-[2,7-bis(3,5-dimethylphenyl)carbazol-9-yl]-3-cyanophenyl]pyrimidine-2-carbonitrile.
Molecular Properties
| Compound Name | 5-[4-[2,7-bis(3,5-dimethylphenyl)carbazol-9-yl]-3-cyanophenyl]pyrimidine-2-carbonitrile |
|---|---|
| PubChem CID | 165401521 |
| Molecular Formula | C40H29N5 |
| Molecular Weight | 579.71 g/mol |
| Exact Mass | 579.24 |
| IUPAC Name | 5-[4-[2,7-bis(3,5-dimethylphenyl)carbazol-9-yl]-3-cyanophenyl]pyrimidine-2-carbonitrile |
| SMILES | Cc1cc(C)cc(-c2ccc3c4ccc(-c5cc(C)cc(C)c5)cc4n(-c4ccc(-c5cnc(C#N)nc5)cc4C#N)c3c2)c1 |
| InChI | InChI=1S/C40H29N5/c1-24-11-25(2)14-31(13-24)29-5-8-35-36-9-6-30(32-15-26(3)12-27(4)16-32)19-39(36)45(38(35)18-29)37-10-7-28(17-33(37)20-41)34-22-43-40(21-42)44-23-34/h5-19,22-23H,1-4H3 |
| InChIKey | BIBFHEUDIYDBIO-UHFFFAOYSA-N |
| XLogP | 9.55 |
| TPSA | 78.29 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 45 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 579.71 |
| LogP ≤ 5 | 9.55 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 165401521 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.